INBIOLEV SL

Their core work

INBIOLEV SL is a Spanish biotechnology SME, likely specializing in biological fermentation processes — the company name strongly suggests a focus on yeast (from Spanish "levadura" or French "levure") and biological innovation. Their most recent and substantive project, ECOBIOMASS, targets wine production optimization through efficient biological processes, placing them in the intersection of agri-food biotech and fermentation science. Their earlier work explored biological identity markers as commercial assets, suggesting a broader capability in applied microbiology or bioinformatics before narrowing to food and beverage production. Based in Aizoain, Navarra — a region adjacent to one of Spain's premier wine zones — their work has clear practical grounding in the local agricultural economy.

What they specialise in

How they've shifted over time

In their earlier H2020 work (2015–2016), INBIOLEV focused on biological identity — essentially, how biological data or bio-markers could be packaged as a competitive commercial asset, a relatively abstract and broad biotechnology concept. By 2019, their focus had shifted sharply and concretely toward agri-food applications, specifically wine production efficiency and biomass use, which is a much more defined and commercially grounded niche. This trajectory suggests the company tested broader biotech concepts first, then converged on a specific industry vertical — fermentation and food biotech — where they had the deepest operational knowledge.

INBIOLEV is consolidating around fermentation biotechnology for premium food and beverage production, and is likely pursuing commercial scale-up of the ECOBIOMASS process given the size of their SME Phase 2 grant.

How they like to work

INBIOLEV has acted as sole coordinator on both of its H2020 projects, with no recorded consortium partners — a pattern typical of SME Instrument grants, which fund individual companies rather than research consortia. This means they are experienced at leading and managing EU-funded innovation projects independently, but have not yet demonstrated ability to integrate into multi-partner research networks. A potential collaborator should expect a self-directed, commercially focused partner rather than an academic consortium builder.

INBIOLEV has no recorded external consortium partners across its two H2020 projects, which reflects the solo-company structure of the SME Instrument funding scheme rather than deliberate isolation. Their collaborative network outside EU projects is unknown from available data.

What sets them apart

INBIOLEV occupies a specific niche at the intersection of fermentation science and premium wine production in Navarra, Spain — a geography that gives them direct proximity to major wine producers and practical testing ground for their biotechnology. Their progression from SME Phase 1 (concept validation) to SME Phase 2 (market-ready development) within H2020 demonstrates that their technology passed competitive EU peer review twice, which is a meaningful quality signal for a small private company. For consortium builders in food biotech or agri-food innovation, they offer applied fermentation expertise backed by commercially oriented R&D rather than purely academic research.

Highlights from their portfolio

• ECOBIOMASS
  At over €1 million in EC funding, this SME Phase 2 grant represents a significant vote of confidence in INBIOLEV's wine production biotechnology and is their largest and most commercially developed project.
• MYBIOASSET
  This SME Phase 1 project reveals an earlier, broader biotechnology ambition — using biological identity markers as business assets — showing the company's capacity to originate and validate novel commercial concepts.